|
|
||||||||
Divisions of 1 Developmental Biology and 2 Pediatric Gastroenterology, Department of Pediatrics, University of Cincinnati College of Medicine and Children's Hospital Research Foundation, Cincinnati, Ohio 45229
Adenosine deaminase (ADA) is expressed at high levels in the epithelium of proximal small intestine. Transgenic mice were used to characterize the regulatory region governing this activation. A duodenum-specific enhancer is located in intron 2 of the human ADA gene at the central site among a cluster of seven DNase I-hypersensitive sites present in duodenal DNA. Flanking DNA, including the remaining hypersensitive sites, is required for consistent high-level enhancer function. The enhancer activates expression in a pattern identical to endogenous ADA along both the anterior-posterior axis of the small intestine and the crypt-villus differentiation axis of the intestinal epithelium. Timing of activation by the central enhancer mimics endogenous mouse ADA activation, occurring at 2-3 wk of age. However, two upstream DNA segments, one proximal and one distal, collaborate to change enhancer activation to a perinatal time point. Studies with duodenal nuclear extracts identified five distinct DNase I footprints within the enhancer. Protected regions encompass six putative binding sites for the transcription factor PDX-1, as well as proposed CDX, hepatocyte nuclear factor-4, and GATA-type sites.
transgenic mice; PDX-1; temporal regulation; crypt-villus axis; cephalocaudal axis; DNase I footprinting
This article has been cited by other articles:
![]() |
N Gassler, D Newrzella, C Bohm, S Lyer, L Li, O Sorgenfrei, L van Laer, B Sido, J Mollenhauer, A Poustka, et al. Molecular characterisation of non-absorptive and absorptive enterocytes in human small intestine Gut, August 1, 2006; 55(8): 1084 - 1089. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Wang, A. Klopot, J.-N. Freund, L. N. Dowling, S. D. Krasinski, and J. C. Fleet Control of differentiation-induced calbindin-D9k gene expression in Caco-2 cells by cdx-2 and HNF-1{alpha} Am J Physiol Gastrointest Liver Physiol, November 1, 2004; 287(5): G943 - G953. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Dusing, E. A. Florence, and D. A. Wiginton High-level activation by a duodenum-specific enhancer requires functional GATA binding sites Am J Physiol Gastrointest Liver Physiol, June 1, 2003; 284(6): G1053 - G1065. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. Jegga, S. P. Sherwood, J. W. Carman, A. T. Pinski, J. L. Phillips, J. P. Pestian, and B. J. Aronow Detection and Visualization of Compositionally Similar cis-Regulatory Element Clusters in Orthologous and Coordinately Controlled Genes Genome Res., September 1, 2002; 12(9): 1408 - 1417. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Y. Lee, Z. Wang, C.-K. Lin, C. H. Contag, L. C. Olds, A. D. Cooper, and E. Sibley Regulation of Intestine-specific Spatiotemporal Expression by the Rat Lactase Promoter J. Biol. Chem., April 5, 2002; 277(15): 13099 - 13105. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Dusing, E. A. Florence, and D. A. Wiginton PDX-1 Is Required for Activation in Vivo from a Duodenum-specific Enhancer J. Biol. Chem., April 20, 2001; 276(17): 14434 - 14442. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Lovshin, J. Estall, B. Yusta, T. J. Brown, and D. J. Drucker Glucagon-like Peptide (GLP)-2 Action in the Murine Central Nervous System Is Enhanced by Elimination of GLP-1 Receptor Signaling J. Biol. Chem., June 8, 2001; 276(24): 21489 - 21499. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |